Identification and Localization of Epoxide Hydrolase 2 (EPHX2) in Various Cell Types

Target Name: EPHX2

NCBI ID: G2053

EPHX2

Identification and Localization of Epoxide Hydrolase 2 (EPHX2) in Various Cell Types

Epoxide hydrolase 2 (EPHX2), also known as cytosolic, is a protein that is expressed in various cell types throughout the body. It is a member of the superfamily of hydrolases, which are a group of enzymes that are involved in the breakdown of macromolecules. EPHX2 is primarily localized to the cytosol of cells, where it is involved in the epoxidation of various lipids, including fatty acids, ceramides, and phospholipids.

The EPHX2 gene was first identified in 2003 and has since been localized to the X chromosome. It is a member of the EPH gene family, which includes several related genes that are involved in the regulation of cell signaling pathways, including EPH1, EPH2, and EPH3. These genes are characterized by the presence of a specific domain, known as the EPH domain, which is responsible for the catalytic activity of the enzyme.

The EPHX2 protein is a 21-kDa protein that is expressed in various cell types, including neurons, macrophages, and dendrites. It is primarily localized to the cytosol of cells, where it is involved in the epoxidation of various lipids. EPHX2 is also known to be involved in the regulation of various cellular processes, including cell signaling, cell adhesion, and cell migration.

One of the main functions of EPHX2 is its role in the epoxidation of fatty acids, which is a critical step in the lipid biosynthesis pathway. In addition to its role in fatty acid metabolism, EPHX2 is also involved in the regulation of various cellular processes, including cell signaling, cell adhesion, and cell migration.

In terms of its potential as a drug target, EPHX2 is an attractive target for drug development due to its unique mechanism of action and its involvement in various cellular processes. One of the main advantages of targeting EPHX2 is its ability to modulate the levels of various cellular signaling pathways, including the regulation of cell adhesion, cell migration, and cell signaling. This makes it an attractive target for the development of drugs that can modulate these processes and improve various cellular functions.

In addition to its potential as a drug target, EPHX2 is also a potential biomarker for various diseases. For example, alterations in the levels of EPHX2 have been observed in various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. These changes in EPHX2 levels can be used as a diagnostic or predictive marker for these diseases, providing valuable information for the development of new therapeutic approaches.

In conclusion, EPHX2 is a protein that is expressed in various cell types and is involved in the epoxidation of various lipids, including fatty acids, ceramides, and phospholipids. Its unique mechanism of action and its involvement in various cellular processes make it an attractive target for drug development. In addition to its potential as a drug target, EPHX2 is also a potential biomarker for various diseases, providing valuable information for the development of new therapeutic approaches. Further research is needed to fully understand the role of EPHX2 in various cellular processes and its potential as a drug target and biomarker.

Protein Name: Epoxide Hydrolase 2

Functions: Bifunctional enzyme (PubMed:12574510). The C-terminal domain has epoxide hydrolase activity and acts on epoxides (alkene oxides, oxiranes) and arene oxides (PubMed:12869654, PubMed:12574510, PubMed:22798687). Plays a role in xenobiotic metabolism by degrading potentially toxic epoxides (By similarity). Also determines steady-state levels of physiological mediators (PubMed:12869654, PubMed:12574510, PubMed:22798687, PubMed:21217101)

The "EPHX2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EPHX2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets